FI971193A0 - Hoidossa käyttökelpoisia kinoksaliinijohdannaisia - Google Patents

Hoidossa käyttökelpoisia kinoksaliinijohdannaisia

Info

Publication number
FI971193A0
FI971193A0 FI971193A FI971193A FI971193A0 FI 971193 A0 FI971193 A0 FI 971193A0 FI 971193 A FI971193 A FI 971193A FI 971193 A FI971193 A FI 971193A FI 971193 A0 FI971193 A0 FI 971193A0
Authority
FI
Finland
Prior art keywords
pct
alkyl
kinoxaline
therapy
derivatives useful
Prior art date
Application number
FI971193A
Other languages
English (en)
Swedish (sv)
Other versions
FI971193A (fi
Inventor
Michael Jonathan Fray
Charles Eric Mowbray
Alan Stobie
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of FI971193A0 publication Critical patent/FI971193A0/fi
Publication of FI971193A publication Critical patent/FI971193A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
FI971193A 1994-09-24 1997-03-21 Hoidossa käyttökelpoisia kinoksaliinijohdannaisia FI971193A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419318A GB9419318D0 (en) 1994-09-24 1994-09-24 Therapeutic agents
PCT/EP1995/003559 WO1996009295A1 (en) 1994-09-24 1995-09-08 Quinoxaline derivatives useful in therapy

Publications (2)

Publication Number Publication Date
FI971193A0 true FI971193A0 (fi) 1997-03-21
FI971193A FI971193A (fi) 1997-05-21

Family

ID=10761869

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971193A FI971193A (fi) 1994-09-24 1997-03-21 Hoidossa käyttökelpoisia kinoksaliinijohdannaisia

Country Status (28)

Country Link
US (1) US5852016A (fi)
EP (1) EP0783495B1 (fi)
JP (1) JP2986920B2 (fi)
KR (1) KR970706261A (fi)
CN (1) CN1158610A (fi)
AT (1) ATE213731T1 (fi)
AU (1) AU688591B2 (fi)
BR (1) BR9504132A (fi)
CA (1) CA2200742C (fi)
CO (1) CO4410336A1 (fi)
CZ (1) CZ85797A3 (fi)
DE (1) DE69525633T2 (fi)
DK (1) DK0783495T3 (fi)
ES (1) ES2171553T3 (fi)
FI (1) FI971193A (fi)
GB (1) GB9419318D0 (fi)
HU (1) HUT77734A (fi)
IL (2) IL115334A0 (fi)
MX (1) MX9702259A (fi)
NO (1) NO971261L (fi)
NZ (1) NZ292922A (fi)
PE (1) PE47596A1 (fi)
PL (1) PL319405A1 (fi)
PT (1) PT783495E (fi)
RU (1) RU2135484C1 (fi)
TR (1) TR199501158A2 (fi)
WO (1) WO1996009295A1 (fi)
ZA (1) ZA958023B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY132385A (en) * 1995-08-31 2007-10-31 Novartis Ag 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
PT784973E (pt) * 1995-10-10 2002-06-28 Pfizer Derivados de quinoxalina para o tratamento de zumbido nos ouvidos
GB9604400D0 (en) 1996-03-01 1996-05-01 Pfizer Ltd Compounds useful in therapy
WO1997046539A1 (en) 1996-06-05 1997-12-11 Warner-Lambert Company Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
US5922715A (en) * 1997-02-18 1999-07-13 American Home Products Corporation 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones
JP2001511805A (ja) * 1997-02-18 2001-08-14 アメリカン・ホーム・プロダクツ・コーポレイション ドパミン作動薬である5−アミノアルコキシ−1,4−ジヒドロキノキサリン−2,3−ジオン
TW526195B (en) 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use
GB0310881D0 (en) * 2003-05-12 2003-06-18 Merck Sharp & Dohme Pharmaceutical formulation
US10208000B2 (en) 2015-12-16 2019-02-19 University Of Kentucky Research Foundation Eis inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE572852C (de) * 1931-03-08 1933-03-24 Willy Messerschmitt Dipl Ing Verfahren zur Herstellung von Flugzeugtragfluegeln mit trapezfoermigem Grundriss
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DE69132340T2 (de) * 1990-11-06 2001-02-08 Yamanouchi Pharma Co Ltd Kondensiertes pyrazinderivat
DE4123106A1 (de) * 1991-07-09 1993-01-14 Schering Ag Arzneimittel zur behandlung von entzugssymptomen
PT101004B (pt) * 1991-10-26 1999-10-29 Schering Ag Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
PT647137E (pt) * 1992-06-22 2008-11-24 Univ California Antagonistas dos receptores da glicina e a sua utilização
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE4439493A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE4439492A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US5614508A (en) * 1995-06-07 1997-03-25 Warner-Lambert Company Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists

Also Published As

Publication number Publication date
PE47596A1 (es) 1996-11-12
US5852016A (en) 1998-12-22
CA2200742A1 (en) 1996-03-28
ATE213731T1 (de) 2002-03-15
KR970706261A (ko) 1997-11-03
DK0783495T3 (da) 2002-04-22
FI971193A (fi) 1997-05-21
DE69525633T2 (de) 2002-08-08
MX9702259A (es) 1997-06-28
PL319405A1 (en) 1997-08-04
NO971261D0 (no) 1997-03-19
CO4410336A1 (es) 1997-01-09
IL126104A0 (en) 1999-05-09
JP2986920B2 (ja) 1999-12-06
GB9419318D0 (en) 1994-11-09
HUT77734A (hu) 1998-07-28
ES2171553T3 (es) 2002-09-16
AU688591B2 (en) 1998-03-12
WO1996009295A1 (en) 1996-03-28
EP0783495B1 (en) 2002-02-27
PT783495E (pt) 2002-07-31
TR199501158A2 (tr) 1997-02-21
JPH09511526A (ja) 1997-11-18
ZA958023B (en) 1997-03-24
DE69525633D1 (de) 2002-04-04
EP0783495A1 (en) 1997-07-16
NZ292922A (en) 1998-07-28
RU2135484C1 (ru) 1999-08-27
CA2200742C (en) 2001-09-11
CN1158610A (zh) 1997-09-03
IL115334A0 (en) 1995-12-31
CZ85797A3 (cs) 1998-09-16
BR9504132A (pt) 1996-08-06
NO971261L (no) 1997-05-05
AU3523295A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
ATE165510T1 (de) Methode zur hemmung der proliferation weiche muskelzellen und der restenose
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
NO166129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-9h-pyrido (3,4-b)indoler.
FI971193A0 (fi) Hoidossa käyttökelpoisia kinoksaliinijohdannaisia
DE69227583T2 (de) Arylmorpholine, herstellung und verwendung
ES2094545T3 (es) Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc..
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
NO20003138L (no) Ny anvendelse av lokalanestetika mot vaskulære hodepiner
DK544689D0 (da) Terapeutisk aktive forbindelser
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
DE60005525D1 (de) 2-aminotetraline zur behandlung von glaukom
DK0662081T3 (da) Ureidoacetamidderivater, deres fremstilling og lægemidler indeholdende disse derivater
ECSP951538A (es) Derivados de quinoxalina utiles en terapia
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE111462T1 (de) 1,4-dihydropyridin-derivate.